Macquarie Group LTD Catalyst Biosciences, Inc. Transaction History

Macquarie Group LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$4.91 - $9.31 $24,991 - $47,387	-5,090 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$7.08 - $10.6 $36,037 - $53,954	5,090 New	5,090 $38,000
Q1 2019 May 15, 2019	SELL	$7.67 - $9.96 $6,136 - $7,968	-800 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$6.59 - $11.28 $5,272 - $9,024	800 New	800 $6,000
Q1 2018 May 11, 2018	SELL	$14.18 - $35.6 $8,508 - $21,360	-600 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$4.52 - $13.69 $2,711 - $8,214	600	600 $8,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.